Search results
Results from the WOW.Com Content Network
This includes hot appliances, bleach, or color treatments in the time leading up to and during chemotherapy. If possible, patients should be given resources to obtain hairpieces or protective scarves before hair loss and educated on the benefits such garments offer, including cold protection in addition to the aesthetic component.
"Bleach is used for lightening hair (to strip the pigment from your hair shaft)," Ikeda says, "It is impossible to make your hair a lighter shade without the help of bleaching or oxidizing agents."
Hair loss, or alopecia, is a fairly common but not universal side effect of ABVD. Hair that is lost returns in the months after completion of chemotherapy. Nausea and vomiting can occur with ABVD, although treatments for chemotherapy-induced nausea and vomiting have improved substantially (see Supportive care below).
Diagram showing which toner color should be used to counteract red, orange and yellow undertones in bleached hair. Toning is a common practice after bleaching to mask the undesirable red and orange tones of "brassy" hair using a toner dye. Through toning, the yellow hue of fully bleached hair can be removed to achieve platinum blond hair.
Laser therapy may help FPHL, alopecia areata, and hair loss after chemotherapy. You may need many laser treatments to get the results you’re looking for, though. Platelet-rich plasma therapy.
3. Medications. Some medications have been associated with temporary hair loss. Most of the time hair loss related to medication is due to the drug disrupting the hair growth cycle leading to a ...
Sometimes hair has a tendency to curl after regrowth, resulting in "chemo curls." Severe hair loss occurs most often with drugs such as doxorubicin, daunorubicin, paclitaxel, docetaxel, cyclophosphamide, ifosfamide and etoposide. Permanent thinning or hair loss can result from some standard chemotherapy regimens. [101]
Alopecia totalis is the loss of all hair on the head and face.Its causes are unclear, but believed to be autoimmune.Research suggests there may be a genetic component linked to developing alopecia totalis; the presence of DRB1*0401 and DQB1*0301, both of which are human leukocyte antigens (HLA), were found to be associated with long-standing alopecia totalis.